Business
Europe investigating rare nerve disorder after AstraZeneca shot – 7NEWS.com.au
Reports have been lodged of a rare nerve-degenerating disorder in people who have received the AstraZeneca vaccine.
Europes medicines regulator says it is reviewing reports of a rare nerve-degenerating disorder in people who have received AstraZenecas COVID-19 vaccine and has requested more detailed data on the cases from the company.
As part of a regular review of safety reports for the vaccine, Vaxzevria, the European Medicines Agencys safety committee is analysing data provided on cases of Guillain-Barre syndrome, the regulator said.
The EMA is also looking into reports of heart inflammation with Pfizer-BioNTechs…
-
Noosa News21 hours agoNew South Wales Blues left to pick up the pieces after fumbling a chance at State of Origin glory
-
Noosa News16 hours agoHelp to make recycling stick
-
Noosa News14 hours agoFormer Darling Downs Zoo employee sheds new light on horrific lion attack on teacher Joanne Cabban
-
Business16 hours agoAlphabet’s stock looks like a brilliant buy right now